1887

Abstract

Hepatitis C virus (HCV) NS3 protein is known to affect normal cellular functions, such as cell proliferation and cell death, and to be involved, either directly or indirectly, in HCV hepatocarcinogenesis. In this study, we demonstrated that NS3 protein could specifically repress the promoter activity of p21 in a dose-dependent manner. The effect was not cell type-specific and was synergistic when combined with HCV core protein. Repression of the p21 promoter by NS3 was almost completely lost when p53 binding sites present on the p21 promoter were removed. Furthermore, p53 binding sites were sufficient to confer a strong NS3 responsiveness to an heterologous promoter, suggesting that NS3 represses the transcription of p21 by modulating the activity of p53. Although the NS3 protein domain required for the majority of p21 repression was located on the protease domain, the proteinase activity itself does not seem to be necessary for repression. Both transcription and protein stability of p53 were unaffected by NS3, suggesting that NS3 might repress transcription of p21 by inhibiting the regulatory activity of p53 via protein–protein interaction(s). Finally, the growth rate of NS3-expressing cell lines was at least twice as fast as that of the parent NIH 3T3 cells, indicating that the repression of p21 is actually reflected by the stimulation of cell growth.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-9-2235
2001-09-01
2019-09-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/9/0822235a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-9-2235&mimeType=html&fmt=ahah

References

  1. Cayrol, C., Knibiehler, M. & Ducommun, B. ( 1998; ). p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16, 311-320.[CrossRef]
    [Google Scholar]
  2. Cho, Y. G., Yoon, J. W., Jang, K. L., Kim, C. M. & Sung, Y. C. ( 1993; ). Full genome cloning and nucleotide sequence analysis of hepatitis C virus from sera of chronic hepatitis patients in Korea. Molecules and Cells 3, 195-202.
    [Google Scholar]
  3. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. & Vogelstein, B. ( 1993; ). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.[CrossRef]
    [Google Scholar]
  4. El-Deiry, W. S., Tokino, T., Waldman, T., Oliner, J. D., Velculescu, V. E., Burrell, M., Hill, D. E., Healy, E., Rees, J. L., Hamilton, S. R., Kinzler, K. W. & Vogelstein, B. ( 1995; ). Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Research 55, 2910-2919.
    [Google Scholar]
  5. Fujita, T., Ishido, S., Muramatsu, S., Itoh, M. & Hotta, H. ( 1996; ). Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. Biochemical and Biophysical Research Communications 229, 825-831.[CrossRef]
    [Google Scholar]
  6. Gorman, C. M. ( 1986; ). High efficiency gene transfer into mammalian cells. In DNA Cloning , pp. 143-190. Edited by D. Glover. Oxford & Washington, DC:IRL Press.
  7. Houghton, M. ( 1996; ). Hepatitis C virus. In Fields Virology , pp. 1035-1058. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia:Lippincott-Raven.
  8. Ishido, S. & Hotta, H. ( 1998; ). Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. FEBS Letters 438, 258-262.[CrossRef]
    [Google Scholar]
  9. Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W. & Vogelstein, B. ( 1992; ). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827-830.[CrossRef]
    [Google Scholar]
  10. Li, R., Waga, S., Hannon, G. J., Beach, D. & Stillman, B. ( 1994; ). Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371, 534-537.[CrossRef]
    [Google Scholar]
  11. Liu, Y., Martindale, J. L., Gorospe, M. & Holbrook, N. J. ( 1996; ). Regulation of p21WAF/Cip1 expression through mitogen-activated protein kinase signaling pathway. Cancer Research 56, 31-35.
    [Google Scholar]
  12. Luo, Y., Hurwitz, J. & Massague, J. ( 1996; ). Cell-cycle inhibition by independent CDK and PCNA binding domains in p21cip1. Nature 375, 159-161.
    [Google Scholar]
  13. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B. & Jacks, T. ( 1995; ). p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes and Development 9, 935-944.[CrossRef]
    [Google Scholar]
  14. Michiell, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E. & Givol, D. ( 1994; ). Induction of WAF1/CIP1 by p53-independent pathway. Cancer Research 54, 3391-3395.
    [Google Scholar]
  15. Morgan, D. O. ( 1995; ). Principles of CDK regulation. Nature 374, 131-134.[CrossRef]
    [Google Scholar]
  16. Otsuka, M., Kato, N., Lan, K. H., Yoshida, H., Kato, J., Goto, T., Shiratori, Y. & Omata, M. ( 2000; ). Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. Journal of Biological Chemistry 275, 34122-34130.[CrossRef]
    [Google Scholar]
  17. Ray, R. B., Steele, R., Meyer, K. & Ray, R. ( 1998; ). Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 208, 331-336.[CrossRef]
    [Google Scholar]
  18. Sakamuro, D., Furukawa, T. & Takegami, T. ( 1995; ). Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. Journal of Virology 69, 3893-3896.
    [Google Scholar]
  19. Suzich, J. A., Tamura, J. K., Palmer-Hill, F., Warrener, P., Grakoui, A., Rice, C. M., Feinstone, S. M. & Collett, M. S. ( 1993; ). Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. Journal of Virology 67, 6152-6158.
    [Google Scholar]
  20. Takegami, S. & Hasumura, Y. ( 1993; ). The difference in immunogenicity among the regions of hepatitis C virus nonstructural protein NS3. Liver 34, 343-344.
    [Google Scholar]
  21. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R. & Beach, D. ( 1993; ). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.[CrossRef]
    [Google Scholar]
  22. Yamada, K., Mori, A., Seki, M., Kimura, J., Yuasa, S., Matsuura, Y. & Miyamura, T. ( 1998; ). Critical point mutations for hepatitis C virus NS3 proteinase. Virology 246, 104-112.[CrossRef]
    [Google Scholar]
  23. Zeng, Y. X. & El-Deiry, W. S. ( 1996; ). Regulation of p21WAF1/ CIP1 expression by p53-independent pathway. Oncogene 12, 1557-1564.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-9-2235
Loading
/content/journal/jgv/10.1099/0022-1317-82-9-2235
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error